Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,9212,940 of 20,252 grants

Active NON-SBIR/STTR RPGS
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

Abstract Despite intensive treatments that often combine surgery, chemotherapy, and radiation, patients with head and neck squamous cell carcinomas (HNSCCs), including oral cavity...

$4.57M
USD
Completed TRAINING, INDIVIDUAL
The Role of Astrocyte Elevated Gene-1 (AEG-1), A Novel Multifunctional Protein, In Chemotherapy-Induced Peripheral Neuropathy
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2023 – 2025

Abstract Chemotherapy-induced peripheral neuropathy (CIPN) is a prominent dose-limiting side effect of chemotherapy treatment and will often result in the discontinuation of a trea...

$337.7K
USD
Active TRAINING, INDIVIDUAL
Multi-functional cellular therapies to overcome tumor heterogeneity and limit toxicity in acute myeloid leukemia
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a devastating disease with only 30% 5-year overall survival. As a blood cancer, AML appears poised to benefit from the revo...

$829.3K
USD
Active TRAINING, INDIVIDUAL
Multi-functional cellular therapies to overcome tumor heterogeneity and limit toxicity in acute myeloid leukemia
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Acute myeloid leukemia (AML) is a devastating disease with only 30% 5-year overall survival. As a blood cancer, AML appears poised to benefit from the revo...

$909.9K
USD
Completed SBIR-STTR RPGS
Development of ALM-488 for nerve and ureter visualization during abdominal surgery
NATIONAL CANCER INSTITUTE Alume Biosciences, Inc United States 2023 – 2025

PROJECT SUMMARY Fundamental to the goals of surgery are functional preservation of critical nerves and minimization of post- operative patient morbidity. Unfortunately, inadvertent...

$9.37M
USD
Active NON-SBIR/STTR RPGS
Testing the efficacy of a decision aid and planning tool for family building after cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

Project Summary/Abstract Up to 93% of young adult female (YA-F) cancer survivors report fertility distress; 30-46% meet criteria for moderate-severe fertility-related trauma. Gonad...

$6.33M
USD
Completed SBIR-STTR RPGS
Development of ALM-488 for nerve and ureter visualization during abdominal surgery
NATIONAL CANCER INSTITUTE Alume Biosciences, Inc United States 2023 – 2025

PROJECT SUMMARY Fundamental to the goals of surgery are functional preservation of critical nerves and minimization of post- operative patient morbidity. Unfortunately, inadvertent...

$8.66M
USD
Completed OTHER RESEARCH-RELATED
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
NATIONAL CANCER INSTITUTE Georgia Institute of Technology United States 2023 – 2025

Engineered T cells that express chimeric antigen receptors (CARs) have shown remarkable efficacy against hematological malignancies. However, broad implementation of CAR T cell the...

$1.11M
USD
Active NON-SBIR/STTR RPGS
Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Project Abstract Microbiota imbalance impacts the development and therapeutic outcome of cancer by altering host immune response and inflammation. Kaposi’s sarcoma (KS) is the most...

$7.84M
USD
Active NON-SBIR/STTR RPGS
Investigating the EBV methylome in PLWH: Discovery and Development of Novel EBV Diagnostics in Plasma and Saliva
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

ABSTRACT EBV(+) lymphomas are an important cause of death in people living with HIV (PLWH). Different patterns of viral and cellular gene expression have been found to characterize...

$6.73M
USD
Active NON-SBIR/STTR RPGS
Testing the efficacy of a decision aid and planning tool for family building after cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

Project Summary/Abstract Up to 93% of young adult female (YA-F) cancer survivors report fertility distress; 30-46% meet criteria for moderate-severe fertility-related trauma. Gonad...

$5.56M
USD
Active NON-SBIR/STTR RPGS
Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2023 – 2028

This application is being submitted in response to the Notice of Special Interest (NOSI) identified as “NOT-CA- 24-032.” Couples where both members smoke (i.e. dual-smoker couples;...

$954.9K
USD
Active NON-SBIR/STTR RPGS
Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2023 – 2028

Project Summary/Abstract Smokers partnered with other smokers (i.e., dual-smoker couples) represent ~2/3 of all smokers. Dual- smoker couples (DSCs) are less likely to try to quit...

$5.05M
USD
Completed NON-SBIR/STTR RPGS
Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness
NATIONAL CANCER INSTITUTE University of Georgia United States 2023 – 2024

Project Summary/Abstract Smokers partnered with other smokers (i.e., dual-smoker couples) represent ~2/3 of all smokers. Dual- smoker couples (DSCs) are less likely to try to quit...

$6.07M
USD
Completed OTHER RESEARCH-RELATED
Democratizing CAR T cell therapy by in situ programming of virus-specific T cells
NATIONAL CANCER INSTITUTE Georgia Institute of Technology United States 2023 – 2025

Engineered T cells that express chimeric antigen receptors (CARs) have shown remarkable efficacy against hematological malignancies. However, broad implementation of CAR T cell the...

$1.11M
USD
Completed NON-SBIR/STTR RPGS
GPU-based SPECT Reconstruction Using Reverse Monte Carlo Simulations
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2025

Project Summary/Abstract Interest in applications of radiopharmaceutical conjugates has notably increased in the last few years for the treatment of a variety of cancers. These con...

$4.23M
USD
Completed NON-SBIR/STTR RPGS
Targeting DNA Mismatches for Auger Electron Radiotherapy
NATIONAL CANCER INSTITUTE Hunter College United States 2023 – 2025

Project Summary/Abstract Mismatched DNA base pairs can arise due to polymerase errors or exposure to genotoxic chemicals. While eukaryotic cells have evolved a sophisticated mismat...

$4.58M
USD
Active NON-SBIR/STTR RPGS
Impact of microbiota on AIDS-Kaposi’s sarcoma development and therapy
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2023 – 2028

Project Abstract Microbiota imbalance impacts the development and therapeutic outcome of cancer by altering host immune response and inflammation. Kaposi’s sarcoma (KS) is the most...

$7.93M
USD
Active NON-SBIR/STTR RPGS
Investigating the EBV methylome in PLWH: Discovery and Development of Novel EBV Diagnostics in Plasma and Saliva
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

ABSTRACT EBV(+) lymphomas are an important cause of death in people living with HIV (PLWH). Different patterns of viral and cellular gene expression have been found to characterize...

$7.14M
USD
Active NON-SBIR/STTR RPGS
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2023 – 2028

Abstract: Bariatric surgery, currently the most effective treatment for morbid obesity, has become increasingly common in the US. Besides substantial and sustained weight loss, bar...

$7.16M
USD